Trust Co. of Vermont Makes New $4.23 Million Investment in Cigna Group $CI

Posted by George Bondi on Aug 18th, 2026

Trust Co. of Vermont bought a new position in Cigna Group (NYSE:CI – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 15,346 shares of the health services provider’s stock, valued at approximately $4,231,000.

Several other institutional investors have also modified their holdings of CI. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group during the 4th quarter valued at about $25,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group during the fourth quarter worth about $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group during the fourth quarter worth about $29,000. Cedar Mountain Advisors LLC boosted its holdings in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new position in Cigna Group in the 2nd quarter valued at about $34,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Guggenheim raised their price target on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Wells Fargo & Company raised their target price on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Barclays upped their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $339.45.

View Our Latest Report on CI

Insider Transactions at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $275.03 on Tuesday. The company’s 50 day simple moving average is $285.73 and its 200-day simple moving average is $281.32. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a market capitalization of $72.67 billion, a price-to-earnings ratio of 11.38, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter last year, the company posted $7.20 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.